News
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date.
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Kevin D’Amour, PhD, was at ViaCyte from 2002 until 2021 and served as the company’s Chief Scientific Officer from 2011 – 2021. At ViaCyte, ...
Melbourne executive Nathan Smith will take the reins as CEO at NeuroScientific Biopharmaceuticals, bringing his strategic and ...
Professor Robin May is stepping down after completing a five-year term in the role, and will take up a new position as ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Prolific Machines, the Photomolecular platform leader, today announced the appointment of Julien Meissonnier, former Chief Scientific Officer of Catalent, to ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
UofL School of Medicine appoints first-ever joint chief scientific officer with UofL Health. expand. ... By Shea Van Hoy – Editor-in-chief, Louisville Business First. Apr 25, 2025.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback